持续流左心室辅助装置作为移植桥接后迟发性右心衰竭的临床意义
本研究分析97例接受持续流左心室辅助装置(LVAD)作为移植桥接并术后至少3个月行右心导管检查的患者,迟发性右心衰竭(LoRVF)发生率为13%,中位时间11个月。LoRVF与术前右室扩张和重度三尖瓣反流、术后右室扩张及三尖瓣反流加重相关,导致心衰住院率46%、15%需紧急移植,并降低总体生存和无心衰住院生存(P<0.0001)。
要点
- LVAD移植桥接后LoRVF发生率13%,中位11个月出现。
- LoRVF增加心衰住院(46%)和紧急移植(15%)风险。
- 常规右心导管和经胸超声心动图有助于早期诊断LoRVF。
核心结论
- LVAD作为移植桥接后LoRVF与更高发病率和更低生存相关。
- 常规右心导管和经胸超声心动图可能有助于在难治性右心衰竭严重并发症出现前早期诊断。
研究设计与样本
- 回顾性分析97例连续接受LVAD作为移植桥接且术后至少3个月行右心导管检查的患者。
- LoRVF定义为中心静脉压>16 mmHg且心脏指数<2.3 l/min/m2同时存在。
主要发现
- LoRVF诊断率为13%,中位诊断时间11个月。
- LoRVF患者术前右室扩张更重且三尖瓣反流更严重。
- LoRVF与术后右室扩张、中重度三尖瓣反流及较低三尖瓣环收缩期位移相关。
- LoRVF导致脑钠肽水平升高、利尿剂需求增加、血红蛋白降低及房颤和消化道出血发生率更高。
- LoRVF患者心衰住院率46%,15%因难治性右心衰竭需紧急移植。
关键数值与推荐
- LoRVF诊断标准:中心静脉压>16 mmHg且心脏指数<2.3 l/min/m2。
临床怎么用
- 对LVAD作为移植桥接的患者,术后应常规行右心导管和经胸超声心动图以早期发现LoRVF。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: The development of late-onset right ventricular failure (LoRVF) that occurs months after a continuous-flow left ventricular assist device (LVAD) is implanted is a clinical problem that warrants investigation. Our goal was to study the incidence, clinical manifestations and prognosis of LoRVF in a population of patients who received an LVAD as bridge to transplantation. METHODS: Data were analysed from 97 consecutive patients who received an LVAD as bridge to transplantation and underwent a right heart catheterization at least 3 months after receiving an LVAD implantation. LoRVF was defined if both haemodynamic criteria of a central venous pressure >16 mmHg and a cardiac index <2.3 l/min/m2 were present. Clinical and echocardiographic variables, hospitalizations for heart failure and survival were compared between patients with and without LoRVF. RESULTS: LoRVF was diagnosed in 13% of patients after a median time of 11 months. Patients with LoRVF presented preoperative worse right ventricular (RV) dilatation and severe tricuspid regurgitation. LORVF was also associated with postoperative RV dilatation, moderate to severe tricuspid regurgitation and lower tricuspid annular plane systolic excursion. LoRVF resulted in increased brain natriuretic peptide levels and the need for diuretics, lower haemoglobin levels and a higher rate of atrial fibrillation and gastrointestinal bleeding. The rate of hospitalizations for heart failure in patients with LoRVF was 46%, and 15% required an urgent transplantation due to refractory RV failure. LoRVF decreased global survival and survival free from hospitalizations for heart failure (P < 0.0001). CONCLUSIONS: LoRVF after the implantation of an LVAD as bridge to transplantation is associated with higher morbidity and lower survival. The results suggest that the routine use of a right heart catheterization and transthoracic echocardiography may contribute to an early diagnosis before further severe complications due to refractory RV failure might occur. ID NUMBER OF THE IRB APPROVAL: AZ-2019-521 on 10 July 2019.
引用
- Ruiz-Cano MJ, Ramazyan L, Schramm R, et al. Clinical implications of late-onset right ventricular failure after implantation of a continuous-flow left ventricular assist device as bridge to transplantation. Eur J Cardiothorac Surg. 2021. PMID: 33783490. doi:10.1093/ejcts/ezab114
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。